levosalbutamol [Ligand Id: 9816] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1002 (Albuterol (r)-form, ASF-1096, Levalbuterol, Levosalbutamol, R-salbutamol, Xopenex)
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Human [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
There should be some charts here, you may need to enable JavaScript!
  • β1-adrenoceptor in Human [GtoPdb: 28] [UniProtKB: P08588]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells B 5.25 pKi 5623.41 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells B 5.25 pKi 5623 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM phenylboronic acid B 5.33 pKi 4677.35 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM phenylboronic acid B 5.33 pKi 4677 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM boric acid B 5.42 pKi 3802 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM boric acid B 5.42 pKi 3801.89 nM Ki Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM phenylboronic acid F 6.34 pEC50 457.09 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM phenylboronic acid F 6.34 pEC50 457 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM boric acid F 6.56 pEC50 275.42 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting in presence of 100 uM boric acid F 6.56 pEC50 275 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting F 6.84 pEC50 145 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
ChEMBL Agonist activity at recombinant human beta2 adrenoceptor expressed in HEK293T cells assessed as increase in IBMX-induced cAMP accumulation using [3H]-cAMP after 30 mins by liquid scintillation counting F 6.84 pEC50 144.54 nM EC50 Bioorg Med Chem (2012) 20: 933-941 [PMID:22182578]
β1-adrenoceptor in Human [GtoPdb: 28] [UniProtKB: P08588]
GtoPdb - - 4.7 pKi - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]
GtoPdb - - 6.2 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]